Study reveals effective strategy to extend the benefit of immunotherapy for prostate cancer – News-Medical.Net

It’s a scientific riddle tangled up in a complex web. How do you turn an immune cold cancer into one that responds to immunotherapy?
Researchers led by the University of Michigan Rogel Cancer Center started with a simple thread: an inhibitor that showed…

Click here to view the original article.